Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Housey Pharmaceutical Research Laboratories L L C currently has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These filings are spread across 2 distinct art units, reflecting the specialized nature of the company's research. The involvement of 2 distinct examiners indicates that each active case is being reviewed independently.
ABRAHAM, AMJAD A is the busiest examiner for the portfolio, with 1 pending office action. The workload is divided among the 2 distinct examiners. This distribution means that no single examiner has a majority of the active filings under their control.
Practitioners managing the current workload must adapt to the requirements of 2 distinct art units. The use of 2 distinct examiners for the active cases suggests that prosecution strategies should be tailored to each individual application. Success in the 1 pending office action with ABRAHAM, AMJAD A will resolve a portion of the current active workload. The outcome of these separate tracks will determine the immediate progress of the company's intellectual property strategy.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ABRAHAM, AMJAD A | 1 | 31.7% | +35.3% |
| HOFFMAN, SUSAN COE | 1 | 54.2% | +25.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18214183 | PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES | ABRAHAM, AMJAD A | 134d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18214183 | PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES | ABRAHAM, AMJAD A | 134d overdue |
| 18116440 | PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES | HOFFMAN, SUSAN COE | — |
| Art Unit | Apps |
|---|---|
| 1663 | 1 |
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18214183 | PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES | ABRAHAM, AMJAD A | 1663 | §102§112 | Final Rejection | 134d overdue | Pending | Jun 26, 2023 |
| 18116440 | PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES | HOFFMAN, SUSAN COE | 1655 | §103Other | Final Rejection | — | Pending | Mar 02, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial